You are here

baricitinib

Lilly beats profit estimates, delays arthritis drug application

Yahoo/Reuters

Tue, 07/25/17 - 08:31 am

Torpedoed by blood clots, Eli Lilly says a baricitinib comeback in rheumatoid arthritis could take years

Endpoints

Tue, 07/25/17 - 08:27 am

rheumatoid arthritis

2 Reasons Eli Lilly is Getting Crushed

Barron's

Wed, 04/26/17 - 12:00 am

Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain

Motley Fool

Mon, 04/17/17 - 12:09 pm

rheumatoid arthritis

The FDA shot down a new rheumatoid arthritis drug — and the companies that make the drug are tumbling

Yahoo/Business Insider

Mon, 04/17/17 - 11:32 am

rheumatoid arthritis

Biotech Movers: OncoMed, Incyte, Omeros

TheStreet.com

Mon, 04/17/17 - 11:22 am

small cell lung cancer

Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug

Marketwatch

Fri, 04/14/17 - 10:48 am

rheumatoid arthritis

We don’t know when (exactly) Lilly will announce the FDA’s baricitinib decision, but watch out for the looming pricing squabble

Endpoints

Thu, 04/13/17 - 11:48 am

4 Drug Stocks With Big News Coming in April

Motley Fool

Tue, 04/4/17 - 12:11 am

Barictinib FDA Delay Only A 'Short-Term Setback' For Eli Lilly, Says Credit Suisse

Yahoo/Benzinga

Tue, 01/17/17 - 10:18 pm

rheumatoid arthritis

FDA delays decision on Lilly and Incyte's arthritis drug

BioPharma Dive

Tue, 01/17/17 - 11:04 am

rheumatoid arthritis

Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs

Yahoo

Thu, 06/9/16 - 10:10 am

rheumatoid arthritis

With competition lurking, Eli Lilly's baricitinib must show unparalled efficacy

Medical Marketing and Media

Wed, 05/11/16 - 10:52 am

3 Big Battles Brewing in Biotech

Motley Fool

Sun, 04/10/16 - 01:50 pm

Synergy Pharmaceuticals

Lilly's new arthritis drug beats placebo in latest successful trial

Fierce Biotech

Thu, 03/31/16 - 08:18 pm

clinical trials

rheumatoid arthritis

Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line

Motley Fool

Sun, 01/31/16 - 01:37 pm

rheumatoid arthritis

How Big a Threat is Eli Lilly to Gilead Sciences?

Bidness, ETC

Wed, 01/20/16 - 08:40 am

Gilead Sciences

Incyte's stock surges after receiving milestone payment from Eli Lilly

Marketwatch

Tue, 01/19/16 - 08:30 am

Gilead joins Pfizer and Eli Lilly in JAK Race

Bidness, ETC

Sun, 12/27/15 - 10:24 am

Gilead Sciences

Lilly, Incyte rheumatoid arthritis drug succeeds in late-stage study

Yahoo/Reuters

Tue, 09/29/15 - 09:14 am

rheumatoid arthritis

Pages